dc.creatorDib, Nahir
dc.creatorFernández, Luciana
dc.creatorSanto, Marisa
dc.creatorOtero, Luis
dc.creatorAlustiza, Fabrisio Eduardo
dc.creatorLiaudat, Ana Cecilia
dc.creatorBosch, Pablo
dc.creatorLavaggi, María Laura
dc.creatorCerecetto, Hugo
dc.creatorGonzález, Mercedes Florencia
dc.date.accessioned2019-05-02T12:49:41Z
dc.date.accessioned2023-03-15T13:59:35Z
dc.date.available2019-05-02T12:49:41Z
dc.date.available2023-03-15T13:59:35Z
dc.date.created2019-05-02T12:49:41Z
dc.date.issued2019-04-23
dc.identifier2405-8440
dc.identifierhttps://doi.org/10.1016/j.heliyon.2019.e01528
dc.identifierhttps://www.heliyon.com/article/e01528/
dc.identifierhttps://www.sciencedirect.com/science/article/pii/S2405844018337435
dc.identifierhttp://hdl.handle.net/20.500.12123/5019
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/6208188
dc.description.abstractPoly(amidoamine) and Poly(propylenimine) dendrimers with different generations and peripheral groups were studied as solubility enhancers and nanocarriers for 7-bromo-2-hydroxy-phenazine N5,N10-dioxide. This compound possesses potential antitumoral and anti-trypanosomal activity, but its low solubility in physiological media precludes its possible application as therapeutic drug. The amino terminated dendrimers association with the active compounds as observed trough NMR studies showed that electrostatic interactions are essential in the solubilization enhancement process. The obtaining of a stable and no cytotoxic formulation makes the drug-carried association a suitable strategy for the generation of a drug delivery system for phenazine derivatives.
dc.languageeng
dc.publisherElsevier
dc.rightsinfo:eu-repo/semantics/openAccess
dc.sourceHeliyon 5 (4) : e01528 (April 2019)
dc.subjectBioquímica
dc.subjectNitrógeno
dc.subjectCitotoxicidad
dc.subjectNanotecnología
dc.subjectBiochemistry
dc.subjectNitrogen
dc.subjectCytotoxicity
dc.subjectNanotechnology
dc.titleFormation of dendrimer-guest complexes as a strategy to increase the solubility of a phenazine N, N′-dioxide derivative with antitumor activity
dc.typeinfo:ar-repo/semantics/artículo
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion


Este ítem pertenece a la siguiente institución